Covered recipient · General Payments record
GREGORY J MATECHAK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,277.06
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.09 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $64.82 | 4 |
| Acerta Pharma LLC | $43.89 | 3 |
| Novo Nordisk AS | $42.34 | 3 |
| IBSA Pharma Inc. | $29.07 | 2 |
| GlaxoSmithKline, LLC. | $25.84 | 1 |
| BIOTRONIK NRO, Inc. | $20.38 | 1 |
| Abbott Laboratories | $16.77 | 1 |
| Amgen Inc. | $16.72 | 1 |
| Lilly USA, LLC | $16.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.77 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125304325 | CMS |
| ABBVIE INC. | $16.30 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981921 | CMS |
| ABBVIE INC. | $15.61 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981923 | CMS |
| ABBVIE INC. | $17.07 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981925 | CMS |
| ABBVIE INC. | $15.84 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104981927 | CMS |
| Amgen Inc. | $16.72 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117320842 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.26 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104384515 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.81 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105569499 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.82 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105614839 | CMS |
| BIOTRONIK NRO, Inc. | $20.38 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153857754 | CMS |
| GlaxoSmithKline, LLC. | $25.84 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116623055 | CMS |
| IBSA Pharma Inc. | $14.82 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142981639 | CMS |
| IBSA Pharma Inc. | $14.25 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142981641 | CMS |
| Lilly USA, LLC | $16.26 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014169 | CMS |
| Novo Nordisk Inc | $14.53 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097448303 | CMS |
| Novo Nordisk Inc | $14.46 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097186243 | CMS |
| Novo Nordisk Inc | $13.35 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097036513 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.